Erminia Ridolo

Erminia Ridolo is a prominent Italian allergist and the director of the Allergy and Clinical Immunology specialization school at the University of Parma. She has played a significant role in the development and evaluation of a new nasal spray formulation of adrenaline for the emergency treatment of anaphylaxis, which is expected to offer a more user-friendly alternative to traditional intramuscular injections, particularly for patients who experience anxiety about needles.